Blackstone Inc
HRMY icon

Blackstone Inc’s Harmony Biosciences HRMY Stock Holding History

Blackstone Inc’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,048,951
Closed -$51.2M – 231
2022
Q2 		$51.2M Hold
1,048,951
– – 0.17% 41
2022
Q1 		$51M Hold
1,048,951
– – 0.13% 60
2021
Q4 		$44.7M Hold
1,048,951
– – 0.11% 70
2021
Q3 		$40.2M Buy
+1,048,951
New +$33.8M 0.09% 79

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $86.2B AUM 12.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Blackstone Inc's HRMY Position: Q3 2022 in Review

Blackstone Inc sold out of Harmony Biosciences (HRMY) in Q3 2022, closing a stake of 1,048,951 shares — an estimated $51.2M sold.

Blackstone Inc first reported a position in HRMY in Q3 2021 and held it in 4 quarters. The position peaked at $51.2M in Q2 2022. 202 funds tracked by Wall St. Rank hold HRMY as of Q3 2022.

  • Blackstone Inc reported no remaining Harmony Biosciences position as of Q3 2022 after selling out during the quarter.
  • Blackstone Inc sold 1,048,951 Harmony Biosciences shares in Q3 2022, an estimated $51.2M.
  • Blackstone Inc first reported a position in Harmony Biosciences in Q3 2021 and held it in 4 quarters.
  • Blackstone Inc's Harmony Biosciences position peaked at $51.2M in Q2 2022.
  • 202 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2022.

Based on Blackstone Inc's 13F filing for Q3 2022, filed 14 Nov 2022.